The global vaccine market was valued at US$ 38.7 billion in 2021. The global vaccine market is expected to witness a CAGR of 10.3% from 2022 to 2030.

Vaccines are mainly aimed at use as a precautionary action in healthy individuals. They are complex biological products designed to protect against infections caused by existing or emerging communicable disease agents (pathogens such as viruses, bacteria, and parasites). Infections are caused by diseases for which traditional pharmaceuticals no longer work (e.g., against antibiotic-resistant bacteria). Their development is a complex and time-consuming process that differs significantly from conventional drug development, making regulatory assessment technically more difficult. Some pathogens, for example, can mutate or have different subtypes. It may be difficult to activate the immune system to respond to the vaccine, among other issues; this significantly challenges vaccine development.

Hepatitis B is a serious and highly transmittable viral disease that can cause severe liver damage and is responsible for chronic liver diseases. Many individuals who have hepatitis have no symptoms. The symptoms of all three types of hepatitis are very similar such as the dark color of urine, stomach-ache: skin or eye yellowing, stool in a light or clay color, fever of moderate frequency, and appetite loss.

Get a Sample PDF Brochure:

Key Players:

  • AstraZeneca plc
  • Bavarian Nordic
  • Bharat Biotech International Ltd.
  • CSL Limited
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline plc.
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Novavax, Inc
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.

By Type

  • Recombinant
  • Live Attenuated
  • Inactivated
  • Toxoid

By Disease

  • Bacterial Vaccines
  • Viral Vaccines
  • Combination Vaccines

Table of Contents

    1. Market Ecosystem 
    2. Timeline Under Consideration
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Recombinant Vaccines
    2. Inactivated Vaccines
    3. Live Attenuated Vaccines 
    4. Toxoid Vaccines
    5. Others


TOC Continued…

Browse the full report now:


About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.